{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:47:26Z","timestamp":1792784846543,"version":"4.5.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2024,7,2]],"date-time":"2024-07-02T00:00:00Z","timestamp":1719878400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,7,2]],"date-time":"2024-07-02T00:00:00Z","timestamp":1719878400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the Science and Technology Program of Guangzhou"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Metastasis is the major culprit of treatment failure in nasopharyngeal carcinoma (NPC). Aryl hydrocarbon receptor nuclear translocator like 2 (ARNTL2), a core circadian gene, plays a crucial role in the development of various tumors. Nevertheless, the biological role and mechanism of ARNTL2 are not fully elucidated in NPC. In this study, ARNTL2 expression was significantly upregulated in NPC tissues and cells. Overexpression of ARNTL2 facilitated NPC cell migration and invasion abilities, while inhibition of ARNTL2 in similarly treated cells blunted migration and invasion abilities in vitro. Consistently, in vivo xenograft tumor models revealed that ARNTL2 silencing reduced nude mice inguinal lymph node and lung metastases, as well as tumor growth. Mechanistically, ARNTL2 negatively regulated the transcription expression of AMOTL2 by directly binding to the AMOTL2 promoter, thus reducing the recruitment and stabilization of AMOTL2 to LATS1\/2 kinases, which strengthened YAP nuclear translocation by suppressing LATS-dependent YAP phosphorylation. Inhibition of AMOTL2 counteracted the effects of ARNTL2 knockdown on NPC cell migration and invasion abilities. These findings suggest that ARNTL2 may be a promising therapeutic target to combat NPC metastasis and further supports the crucial roles of circadian genes in cancer development.<\/jats:p>","DOI":"10.1038\/s41419-024-06860-x","type":"journal-article","created":{"date-parts":[[2024,7,2]],"date-time":"2024-07-02T06:02:16Z","timestamp":1719900136000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["The circadian gene ARNTL2 promotes nasopharyngeal carcinoma invasiveness and metastasis through suppressing AMOTL2-LATS-YAP pathway"],"prefix":"10.1038","volume":"15","author":[{"given":"Wenqing","family":"Zou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiming","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cong","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongjun","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunxin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaobo","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weijie","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiqing","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiwei","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingjie","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0341-2620","authenticated-orcid":false,"given":"Han","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8654-3636","authenticated-orcid":false,"given":"Na","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1027-071X","authenticated-orcid":false,"given":"Yanping","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,7,2]]},"reference":[{"key":"6860_CR1","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/s0140-6736(19)30956-0","volume":"394","author":"YP Chen","year":"2019","unstructured":"Chen YP, Chan ATC, Le QT, Blanchard P, Sun Y, Ma J. Nasopharyngeal carcinoma. Lancet. 2019;394:64\u201380. https:\/\/doi.org\/10.1016\/s0140-6736(19)30956-0","journal-title":"Lancet"},{"key":"6860_CR2","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1001\/jamaoncol.2022.2810","volume":"8","author":"H Qiao","year":"2022","unstructured":"Qiao H, Tan XR, Li H, Li JY, Chen XZ, Li YQ, et al. Association of intratumoral microbiota with prognosis in patients with nasopharyngeal carcinoma from 2 hospitals in China. JAMA Oncol. 2022;8:1301\u20139. https:\/\/doi.org\/10.1001\/jamaoncol.2022.2810","journal-title":"JAMA Oncol"},{"key":"6860_CR3","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.radonc.2015.02.017","volume":"115","author":"X Wang","year":"2015","unstructured":"Wang X, Hu C, Ying H, He X, Zhu G, Kong L, et al. Patterns of lymph node metastasis from nasopharyngeal carcinoma based on the 2013 updated consensus guidelines for neck node levels. Radiother Oncol. 2015;115:41\u20135. https:\/\/doi.org\/10.1016\/j.radonc.2015.02.017","journal-title":"Radiother Oncol"},{"key":"6860_CR4","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.radonc.2013.10.020","volume":"110","author":"X Sun","year":"2014","unstructured":"Sun X, Su S, Chen C, Han F, Zhao C, Xiao W, et al. Long-term outcomes of intensity-modulated radiotherapy for 868 patients with nasopharyngeal carcinoma: an analysis of survival and treatment toxicities. Radiother Oncol. 2014;110:398\u2013403. https:\/\/doi.org\/10.1016\/j.radonc.2013.10.020","journal-title":"Radiother Oncol"},{"key":"6860_CR5","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1056\/NEJMoa1905287","volume":"381","author":"Y Zhang","year":"2019","unstructured":"Zhang Y, Chen L, Hu GQ, Zhang N, Zhu XD, Yang KY, et al. Gemcitabine and cisplatin induction chemotherapy in nasopharyngeal carcinoma. N Engl J Med. 2019;381:1124\u201335. https:\/\/doi.org\/10.1056\/NEJMoa1905287","journal-title":"N Engl J Med"},{"key":"6860_CR6","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1056\/NEJMoa1701717","volume":"377","author":"KCA Chan","year":"2017","unstructured":"Chan KCA, Woo JKS, King A, Zee BCY, Lam WKJ, Chan SL, et al. Analysis of plasma Epstein-Barr virus DNA to screen for nasopharyngeal cancer. N Engl J Med. 2017;377:513\u201322. https:\/\/doi.org\/10.1056\/NEJMoa1701717","journal-title":"N Engl J Med"},{"key":"6860_CR7","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1038\/nrg.2016.150","volume":"18","author":"JS Takahashi","year":"2017","unstructured":"Takahashi JS. Transcriptional architecture of the mammalian circadian clock. Nat Rev Genet. 2017;18:164\u201379. https:\/\/doi.org\/10.1038\/nrg.2016.150","journal-title":"Nat Rev Genet"},{"key":"6860_CR8","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1016\/s1470-2045(09)70358-4","volume":"10","author":"R Baan","year":"2009","unstructured":"Baan R, Grosse Y, Straif K, Secretan B, El Ghissassi F, Bouvard V, et al. A review of human carcinogens\u2013Part F: chemical agents and related occupations. Lancet Oncol. 2009;10:1143\u20134. https:\/\/doi.org\/10.1016\/s1470-2045(09)70358-4","journal-title":"Lancet Oncol"},{"key":"6860_CR9","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.smrv.2012.08.003","volume":"17","author":"EL Haus","year":"2013","unstructured":"Haus EL, Smolensky MH. Shift work and cancer risk: potential mechanistic roles of circadian disruption, light at night, and sleep deprivation. Sleep Med Rev. 2013;17:273\u201384. https:\/\/doi.org\/10.1016\/j.smrv.2012.08.003","journal-title":"Sleep Med Rev"},{"key":"6860_CR10","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1093\/jnci\/95.11.825","volume":"95","author":"ES Schernhammer","year":"2003","unstructured":"Schernhammer ES, Laden F, Speizer FE, Willett WC, Hunter DJ, Kawachi I, et al. Night-shift work and risk of colorectal cancer in the nurses\u2019 health study. J Natl Cancer Inst. 2003;95:825\u20138. https:\/\/doi.org\/10.1093\/jnci\/95.11.825","journal-title":"J Natl Cancer Inst"},{"key":"6860_CR11","doi-asserted-by":"publisher","first-page":"211","DOI":"10.23938\/assn.0307","volume":"41","author":"E Salamanca-Fern\u00e1ndez","year":"2018","unstructured":"Salamanca-Fern\u00e1ndez E, Rodr\u00edguez-Barranco M, Guevara M, Ardanaz E, Olry de Labry Lima A, S\u00e1nchez MJ. Night-shift work and breast and prostate cancer risk: updating the evidence from epidemiological studies. An Sist Sanit Navar. 2018;41:211\u201326. https:\/\/doi.org\/10.23938\/assn.0307","journal-title":"An Sist Sanit Navar"},{"key":"6860_CR12","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.cmet.2016.07.001","volume":"24","author":"T Papagiannakopoulos","year":"2016","unstructured":"Papagiannakopoulos T, Bauer MR, Davidson SM, Heimann M, Subbaraj L, Bhutkar A, et al. Circadian rhythm disruption promotes lung tumorigenesis. Cell Metab. 2016;24:324\u201331. https:\/\/doi.org\/10.1016\/j.cmet.2016.07.001","journal-title":"Cell Metab"},{"key":"6860_CR13","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.canlet.2017.05.022","volume":"402","author":"SL Liu","year":"2017","unstructured":"Liu SL, Lin HX, Lin CY, Sun XQ, Ye LP, Qiu F, et al. TIMELESS confers cisplatin resistance in nasopharyngeal carcinoma by activating the Wnt\/\u03b2-catenin signaling pathway and promoting the epithelial mesenchymal transition. Cancer Lett. 2017;402:117\u201330. https:\/\/doi.org\/10.1016\/j.canlet.2017.05.022","journal-title":"Cancer Lett"},{"key":"6860_CR14","doi-asserted-by":"publisher","first-page":"5336","DOI":"10.1039\/d0tb00595a","volume":"8","author":"L Hou","year":"2020","unstructured":"Hou L, Li H, Wang H, Ma D, Liu J, Ma L, et al. The circadian clock gene PER2 enhances chemotherapeutic efficacy in nasopharyngeal carcinoma when combined with a targeted nanosystem. J Mater Chem B. 2020;8:5336\u201350. https:\/\/doi.org\/10.1039\/d0tb00595a","journal-title":"J Mater Chem B"},{"key":"6860_CR15","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s13046-018-0997-7","volume":"38","author":"H Peng","year":"2019","unstructured":"Peng H, Zhang J, Zhang PP, Chen L, Tang LL, Yang XJ, et al. ARNTL hypermethylation promotes tumorigenesis and inhibits cisplatin sensitivity by activating CDK5 transcription in nasopharyngeal carcinoma. J Exp Clin Cancer Res. 2019;38:11 https:\/\/doi.org\/10.1186\/s13046-018-0997-7","journal-title":"J Exp Clin Cancer Res"},{"key":"6860_CR16","doi-asserted-by":"publisher","first-page":"Rc83","DOI":"10.1523\/JNEUROSCI.20-13-j0002.2000","volume":"20","author":"JB Hogenesch","year":"2000","unstructured":"Hogenesch JB, Gu YZ, Moran SM, Shimomura K, Radcliffe LA, Takahashi JS, et al. The basic helix-loop-helix-PAS protein MOP9 is a brain-specific heterodimeric partner of circadian and hypoxia factors. J Neurosci. 2000;20:Rc83 https:\/\/doi.org\/10.1523\/JNEUROSCI.20-13-j0002.2000","journal-title":"J Neurosci"},{"key":"6860_CR17","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/s0378-1119(02)00928-9","volume":"298","author":"A Bratt","year":"2002","unstructured":"Bratt A, Wilson WJ, Troyanovsky B, Aase K, Kessler R, Van Meir EG, et al. Angiomotin belongs to a novel protein family with conserved coiled-coil and PDZ binding domains. Gene. 2002;298:69\u201377. https:\/\/doi.org\/10.1016\/s0378-1119(02)00928-9","journal-title":"Gene"},{"key":"6860_CR18","doi-asserted-by":"publisher","first-page":"34859","DOI":"10.1074\/jbc.M503915200","volume":"280","author":"A Bratt","year":"2005","unstructured":"Bratt A, Birot O, Sinha I, Veitonm\u00e4ki N, Aase K, Ernkvist M, et al. Angiomotin regulates endothelial cell-cell junctions and cell motility. J Biol Chem. 2005;280:34859\u201369. https:\/\/doi.org\/10.1074\/jbc.M503915200","journal-title":"J Biol Chem"},{"key":"6860_CR19","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1242\/dev.02782","volume":"134","author":"H Huang","year":"2007","unstructured":"Huang H, Lu FI, Jia S, Meng S, Cao Y, Wang Y, et al. Amotl2 is essential for cell movements in zebrafish embryo and regulates c-Src translocation. Development. 2007;134:979\u201388. https:\/\/doi.org\/10.1242\/dev.02782","journal-title":"Development"},{"key":"6860_CR20","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1016\/j.cellsig.2016.08.004","volume":"28","author":"HJ Janse van Rensburg","year":"2016","unstructured":"Janse van Rensburg HJ, Yang X. The roles of the Hippo pathway in cancer metastasis. Cell Signal. 2016;28:1761\u201372. https:\/\/doi.org\/10.1016\/j.cellsig.2016.08.004","journal-title":"Cell Signal"},{"key":"6860_CR21","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/nature10137","volume":"474","author":"S Dupont","year":"2011","unstructured":"Dupont S, Morsut L, Aragona M, Enzo E, Giulitti S, Cordenonsi M, et al. Role of YAP\/TAZ in mechanotransduction. Nature. 2011;474:179\u201383. https:\/\/doi.org\/10.1038\/nature10137","journal-title":"Nature"},{"key":"6860_CR22","doi-asserted-by":"publisher","first-page":"2747","DOI":"10.1101\/gad.1602907","volume":"21","author":"B Zhao","year":"2007","unstructured":"Zhao B, Wei X, Li W, Udan RS, Yang Q, Kim J, et al. Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control. Genes Dev. 2007;21:2747\u201361. https:\/\/doi.org\/10.1101\/gad.1602907","journal-title":"Genes Dev"},{"key":"6860_CR23","doi-asserted-by":"publisher","unstructured":"Lodge EJ, Santambrogio A, Russell JP, Xekouki P, Jacques TS, Johnson RL, et al. Homeostatic and tumourigenic activity of SOX2+ pituitary stem cells is controlled by the LATS\/YAP\/TAZ cascade. eLife. 2019;8. https:\/\/doi.org\/10.7554\/eLife.43996","DOI":"10.7554\/eLife.43996"},{"key":"6860_CR24","doi-asserted-by":"publisher","first-page":"3725","DOI":"10.1091\/mbc.E11-04-0300","volume":"22","author":"M Paramasivam","year":"2011","unstructured":"Paramasivam M, Sarkeshik A, Yates JR 3rd, Fernandes MJ, McCollum D. Angiomotin family proteins are novel activators of the LATS2 kinase tumor suppressor. Mol Biol Cell. 2011;22:3725\u201333. https:\/\/doi.org\/10.1091\/mbc.E11-04-0300","journal-title":"Mol Biol Cell"},{"key":"6860_CR25","doi-asserted-by":"publisher","first-page":"18230","DOI":"10.1074\/jbc.RA118.004187","volume":"293","author":"S Mana-Capelli","year":"2018","unstructured":"Mana-Capelli S, McCollum D. Angiomotins stimulate LATS kinase autophosphorylation and act as scaffolds that promote Hippo signaling. J Biol Chem. 2018;293:18230\u201341. https:\/\/doi.org\/10.1074\/jbc.RA118.004187","journal-title":"J Biol Chem"},{"key":"6860_CR26","doi-asserted-by":"publisher","first-page":"64","DOI":"10.15252\/embr.201540809","volume":"17","author":"M Kim","year":"2016","unstructured":"Kim M, Kim M, Park SJ, Lee C, Lim DS. Role of Angiomotin-like 2 mono-ubiquitination on YAP inhibition. EMBO Rep. 2016;17:64\u201378. https:\/\/doi.org\/10.15252\/embr.201540809","journal-title":"EMBO Rep"},{"key":"6860_CR27","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.trecan.2019.07.002","volume":"5","author":"G Sulli","year":"2019","unstructured":"Sulli G, Lam MTY, Panda S. Interplay between circadian clock and cancer: new frontiers for cancer treatment. Trends Cancer. 2019;5:475\u201394. https:\/\/doi.org\/10.1016\/j.trecan.2019.07.002","journal-title":"Trends Cancer"},{"key":"6860_CR28","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/s0092-8674(02)00961-3","volume":"111","author":"L Fu","year":"2002","unstructured":"Fu L, Pelicano H, Liu J, Huang P, Lee C. The circadian gene Period2 plays an important role in tumor suppression and DNA damage response in vivo. Cell. 2002;111:41\u201350. https:\/\/doi.org\/10.1016\/s0092-8674(02)00961-3","journal-title":"Cell"},{"key":"6860_CR29","doi-asserted-by":"publisher","first-page":"2560","DOI":"10.1038\/oby.2007.308","volume":"15","author":"X Wu","year":"2007","unstructured":"Wu X, Zvonic S, Floyd ZE, Kilroy G, Goh BC, Hernandez TL, et al. Induction of circadian gene expression in human subcutaneous adipose-derived stem cells. Obesity. 2007;15:2560\u201370. https:\/\/doi.org\/10.1038\/oby.2007.308","journal-title":"Obesity"},{"key":"6860_CR30","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1158\/1078-0432.Ccr-13-0171","volume":"20","author":"ZL Zeng","year":"2014","unstructured":"Zeng ZL, Luo HY, Yang J, Wu WJ, Chen DL, Huang P, et al. Overexpression of the circadian clock gene Bmal1 increases sensitivity to oxaliplatin in colorectal cancer. Clin Cancer Res. 2014;20:1042\u201352. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-13-0171","journal-title":"Clin Cancer Res"},{"key":"6860_CR31","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.ccell.2016.03.003","volume":"29","author":"JJ Brady","year":"2016","unstructured":"Brady JJ, Chuang CH, Greenside PG, Rogers ZN, Murray CW, Caswell DR, et al. An Arntl2-driven secretome enables lung adenocarcinoma metastatic self-sufficiency. Cancer Cell. 2016;29:697\u2013710. https:\/\/doi.org\/10.1016\/j.ccell.2016.03.003","journal-title":"Cancer Cell"},{"key":"6860_CR32","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1007\/s00432-011-1126-6","volume":"138","author":"G Mazzoccoli","year":"2012","unstructured":"Mazzoccoli G, Pazienza V, Panza A, Valvano MR, Benegiamo G, Vinciguerra M, et al. ARNTL2 and SERPINE1: potential biomarkers for tumor aggressiveness in colorectal cancer. J Cancer Res Clin Oncol. 2012;138:501\u201311. https:\/\/doi.org\/10.1007\/s00432-011-1126-6","journal-title":"J Cancer Res Clin Oncol"},{"key":"6860_CR33","first-page":"1293","volume":"12","author":"M Lu","year":"2020","unstructured":"Lu M, Huang L, Tang Y, Sun T, Li J, Xiao S, et al. ARNTL2 knockdown suppressed the invasion and migration of colon carcinoma: decreased SMOC2-EMT expression through inactivation of PI3K\/AKT pathway. Am J Transl Res. 2020;12:1293\u2013308.","journal-title":"Am J Transl Res"},{"key":"6860_CR34","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1038\/s41419-020-02839-6","volume":"11","author":"Z Wang","year":"2020","unstructured":"Wang Z, Liu T, Xue W, Fang Y, Chen X, Xu L, et al. ARNTL2 promotes pancreatic ductal adenocarcinoma progression through TGF\/BETA pathway and is regulated by miR-26a-5p. Cell Death Dis. 2020;11:692 https:\/\/doi.org\/10.1038\/s41419-020-02839-6","journal-title":"Cell Death Dis"},{"key":"6860_CR35","doi-asserted-by":"publisher","first-page":"772","DOI":"10.7150\/ijbs.19603","volume":"13","author":"M Lv","year":"2017","unstructured":"Lv M, Shen Y, Yang J, Li S, Wang B, Chen Z, et al. Angiomotin family members: oncogenes or tumor suppressors? Int J Biol Sci. 2017;13:772\u201381. https:\/\/doi.org\/10.7150\/ijbs.19603","journal-title":"Int J Biol Sci"},{"key":"6860_CR36","doi-asserted-by":"publisher","unstructured":"Chen X, Lu Y, Guo G, Zhang Y, Sun Y, Guo L, et al. AMOTL2\u2011knockdown promotes the proliferation, migration and invasion of glioma by regulating \u03b2\u2011catenin nuclear localization. Oncol Rep. 2021;46. https:\/\/doi.org\/10.3892\/or.2021.8090.","DOI":"10.3892\/or.2021.8090"},{"key":"6860_CR37","doi-asserted-by":"publisher","first-page":"4364","DOI":"10.1074\/jbc.C110.205401","volume":"286","author":"W Wang","year":"2011","unstructured":"Wang W, Huang J, Chen J. Angiomotin-like proteins associate with and negatively regulate YAP1. J Biol Chem. 2011;286:4364\u201370. https:\/\/doi.org\/10.1074\/jbc.C110.205401","journal-title":"J Biol Chem"},{"key":"6860_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms5557","volume":"5","author":"M Mojallal","year":"2014","unstructured":"Mojallal M, Zheng Y, Hultin S, Audebert S, van Harn T, Johnsson P, et al. AmotL2 disrupts apical-basal cell polarity and promotes tumour invasion. Nat Commun. 2014;5:4557 https:\/\/doi.org\/10.1038\/ncomms5557","journal-title":"Nat Commun"},{"key":"6860_CR39","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1101\/gad.2000111","volume":"25","author":"B Zhao","year":"2011","unstructured":"Zhao B, Li L, Lu Q, Wang LH, Liu CY, Lei Q, et al. Angiomotin is a novel Hippo pathway component that inhibits YAP oncoprotein. Genes Dev. 2011;25:51\u201363. https:\/\/doi.org\/10.1101\/gad.2000111","journal-title":"Genes Dev"},{"key":"6860_CR40","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1101\/gad.210773.112","volume":"27","author":"FX Yu","year":"2013","unstructured":"Yu FX, Guan KL. The Hippo pathway: regulators and regulations. Genes Dev. 2013;27:355\u201371. https:\/\/doi.org\/10.1101\/gad.210773.112","journal-title":"Genes Dev"},{"key":"6860_CR41","doi-asserted-by":"publisher","first-page":"4662","DOI":"10.1038\/onc.2017.101","volume":"36","author":"H Han","year":"2017","unstructured":"Han H, Yang B, Wang W. Angiomotin-like 2 interacts with and negatively regulates AKT. Oncogene. 2017;36:4662\u20139. https:\/\/doi.org\/10.1038\/onc.2017.101","journal-title":"Oncogene"},{"key":"6860_CR42","doi-asserted-by":"publisher","first-page":"19387","DOI":"10.1074\/jbc.M115.656587","volume":"290","author":"N Artinian","year":"2015","unstructured":"Artinian N, Cloninger C, Holmes B, Benavides-Serrato A, Bashir T, Gera J. Phosphorylation of the Hippo pathway component AMOTL2 by the mTORC2 kinase promotes YAP signaling, resulting in enhanced glioblastoma growth and invasiveness. J Biol Chem. 2015;290:19387\u2013401. https:\/\/doi.org\/10.1074\/jbc.M115.656587","journal-title":"J Biol Chem"},{"key":"6860_CR43","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.oraloncology.2017.05.015","volume":"71","author":"ML Ooft","year":"2017","unstructured":"Ooft ML, van Ipenburg JA, Braunius WW, Zuur CI, Koljenovi\u0107 S, Willems SM. Prognostic role of tumor infiltrating lymphocytes in EBV positive and EBV negative nasopharyngeal carcinoma. Oral Oncol. 2017;71:16\u201325. https:\/\/doi.org\/10.1016\/j.oraloncology.2017.05.015","journal-title":"Oral Oncol"},{"key":"6860_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-28158-2","volume":"13","author":"Y Chen","year":"2022","unstructured":"Chen Y, Zhao Y, Yang X, Ren X, Huang S, Gong S, et al. USP44 regulates irradiation-induced DNA double-strand break repair and suppresses tumorigenesis in nasopharyngeal carcinoma. Nat Commun. 2022;13:501 https:\/\/doi.org\/10.1038\/s41467-022-28158-2","journal-title":"Nat Commun"},{"key":"6860_CR45","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-36523-y","volume":"14","author":"JY Li","year":"2023","unstructured":"Li JY, Zhao Y, Gong S, Wang MM, Liu X, He QM, et al. TRIM21 inhibits irradiation-induced mitochondrial DNA release and impairs antitumour immunity in nasopharyngeal carcinoma tumour models. Nat Commun. 2023;14:865 https:\/\/doi.org\/10.1038\/s41467-023-36523-y","journal-title":"Nat Commun"},{"key":"6860_CR46","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-021-01317-7","volume":"20","author":"JY Li","year":"2021","unstructured":"Li JY, Chen YP, Li YQ, Liu N, Ma J. Chemotherapeutic and targeted agents can modulate the tumor microenvironment and increase the efficacy of immune checkpoint blockades. Mol Cancer. 2021;20:27 https:\/\/doi.org\/10.1186\/s12943-021-01317-7","journal-title":"Mol Cancer"},{"key":"6860_CR47","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.818411","volume":"13","author":"WQ Zou","year":"2022","unstructured":"Zou WQ, Luo WJ, Feng YF, Liu F, Liang SB, Fang XL, et al. Expression profiles and prognostic value of multiple inhibitory checkpoints in head and neck lymphoepithelioma-like carcinoma. Front Immunol. 2022;13:818411 https:\/\/doi.org\/10.3389\/fimmu.2022.818411","journal-title":"Front Immunol"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-024-06860-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-024-06860-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-024-06860-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,2]],"date-time":"2024-07-02T06:02:29Z","timestamp":1719900149000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-024-06860-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,2]]},"references-count":47,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2024,7]]}},"alternative-id":["6860"],"URL":"https:\/\/doi.org\/10.1038\/s41419-024-06860-x","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,2]]},"assertion":[{"value":"19 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was approved by the Institutional Ethical Review Board and the Institutional Animal Care and Use Ethics Committee of Sun Yat-sen University Cancer Center (approval number: B2024-227 and L0255202107006).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}],"article-number":"466"}}